Zacks Investment Research
01 Oct 2026, 17:40 UTC · 23h ago
Verdict
Headline takes no side. We score CLX −0.60 across three claims — strongly bearish.
−0.60strongly bearish
More negative than 78% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
The Zacks Consensus Estimate for Clorox's current quarter fell from $1.26 to 99 cents per share over the last 60 days.
Priced intrend over last 60 days
So whatThis 21% drop in consensus EPS suggests a significant earnings miss relative to prior expectations for the next print.
More negative than 95% of claims this week
Six analysts have revised their estimates downward for Clorox's current quarter in the last 60 days, with zero upward revisions.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Priced intrend over last 60 days
So whatThe complete lack of positive revisions signals a bearish consensus that may pressure the multiple.
More negative than 86% of claims this week
The October 16, 2026 $175.00 Put option exhibited some of the highest implied volatility among all equity options on October 1.
Newstated as happening 'today' Oct 01
More negative than 78% of claims this week
Which stocks this story touches
More negative than 78% of ticker scores this week
The company has a Hold rank, is in a bottom-tier industry, and has seen six downward analyst estimate revisions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
2h ago
−1.2%
Price agrees with the score
$80.03 vs $81.01 close before publication (Sep 30) · not market-adjusted
CLX chart →
